VUF-6002
Systematic (IUPAC) name | |
---|---|
(6-chloro-1H-benzimidazol-2-yl)-(4-methylpiperazin-1-yl)methanone | |
Identifiers | |
CAS Number | 869497-75-6 |
PubChem | CID 10446295 |
IUPHAR/BPS | 1277 |
Chemical data | |
Formula | C13H15ClN4O |
Molar mass | 278.737 g/mol |
| |
(verify) |
VUF-6002 (JNJ-10191584) is a drug which acts as a potent and selective antagonist at the histamine H4 receptor.[1] It has antiinflammatory and analgesic effects in animal studies of acute inflammation.[2]
See also
References
- ↑ Zhang, M; Thurmond, RL; Dunford, PJ (2007). "The histamine H(4) receptor: a novel modulator of inflammatory and immune disorders". Pharmacology & therapeutics 113 (3): 594–606. doi:10.1016/j.pharmthera.2006.11.008. PMID 17275092.
- ↑ Coruzzi, G; Adami, M; Guaita, E; De Esch, IJ; Leurs, R (2007). "Antiinflammatory and antinociceptive effects of the selective histamine H4-receptor antagonists JNJ7777120 and VUF6002 in a rat model of carrageenan-induced acute inflammation". European Journal of Pharmacology 563 (1–3): 240–4. doi:10.1016/j.ejphar.2007.02.026. PMID 17382315.
|
This article is issued from Wikipedia - version of the Monday, January 04, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.